|
| |
| | 00663 | | 20.08.2002 | | MSD Merck Sharp & Dohme AG | | | | | | | | | | | | 08.08. | | | | 08.08. | | IP |
| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
---|
01 | HBVAXPRO 10 | Injektionssuspension | Injection suspension (Hepatitidis b viri Antigenum Adnr 10 µg/ml) | J07BC01 | | 02 | HBVAXPRO 10 | | (Vaccinum Hepatitidis b (Adnr) Hbsag 10 mcg) | | |
|
|
|